Current Advances and Travails in Islet Transplantation
暂无分享,去创建一个
D. Harlan | N. Kenyon | O. Korsgren | B. Roep
[1] M. Trucco,et al. Endoscopic Gastric Submucosal Transplantation of Islets (ENDO‐STI): Technique and Initial Results in Diabetic Pigs , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] B. Hirshberg. Implications of the 2008 update from the collaborative islet transplant registry , 2009, Current diabetes reports.
[3] C. Mathieu,et al. Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients , 2009, Diabetes.
[4] C. Mathieu,et al. Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies , 2009, Diabetes Care.
[5] James M. Wilson. A History Lesson for Stem Cells , 2009, Science.
[6] R. Stewart,et al. Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.
[7] D. Roelen,et al. Allograft‐Specific Cytokine Profiles Associate with Clinical Outcome After Islet Cell Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] P. Chaffanjon,et al. Long‐Term Survival of Nonhuman Primate Islets Implanted in an Omental Pouch on a Biodegradable Scaffold , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] C. Mathieu,et al. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation , 2008, Clinical and experimental immunology.
[10] B. Hering,et al. 2008 Update From the Collaborative Islet Transplant Registry , 2008, Transplantation.
[11] G. Szot,et al. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice , 2008, Proceedings of the National Academy of Sciences.
[12] B. Hering,et al. Prolonged Insulin Independence After Islet Allotransplants in Recipients with Type 1 Diabetes , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] Johnny Ludvigsson,et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. , 2008, The New England journal of medicine.
[14] M. Bhasin,et al. Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice , 2008, Proceedings of the National Academy of Sciences.
[15] N. Chao. Faculty Opinions recommendation of In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. , 2008 .
[16] Douglas A. Melton,et al. In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.
[17] Takashi Aoi,et al. Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells , 2008, Science.
[18] B. Alizadeh,et al. Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation , 2008, PloS one.
[19] E. Bonifacio,et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. , 2008, The Journal of clinical investigation.
[20] Christophe Magnan,et al. mTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes , 2008, Diabetes.
[21] E. Kroon,et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.
[22] J. Permert,et al. Intramuscular Autotransplantation of Pancreatic Islets in a 7‐Year‐Old Child: A 2‐Year Follow‐Up , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] W. Uhl,et al. Partial Pancreatectomy in Adult Humans Does Not Provoke β-Cell Regeneration , 2008, Diabetes.
[24] C. Ricordi,et al. Allosensitization of Islet Allograft Recipients , 2007, Transplantation.
[25] C. Ricordi,et al. Rapamycin Impairs In Vivo Proliferation of Islet Beta-Cells , 2007, Transplantation.
[26] W. Sanger,et al. Producing primate embryonic stem cells by somatic cell nuclear transfer , 2007, Nature.
[27] A. M. Shapiro,et al. High Risk of Sensitization After Failed Islet Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] Gao Huang,et al. Human Islets Derived From Donors After Cardiac Death Are Fully Biofunctional , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] H. Rilo,et al. The pancreas as an islet transplantation site. Confirmation in a syngeneic rodent and canine autotransplant model. , 2007, JOP : Journal of the pancreas.
[30] D. Melton,et al. Recovery from diabetes in mice by β cell regeneration , 2007 .
[31] R. Jordan,et al. Interference with Tissue Factor Prolongs Intrahepatic Islet Allograft Survival in a Nonhuman Primate Marginal Mass Model , 2007, Transplantation.
[32] O. Korsgren,et al. Effects of Immunosuppressive Drugs on In Vitro Neogenesis of Human Islets: Mycophenolate Mofetil Inhibits the Proliferation of Ductal Cells , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[33] D. Melton,et al. Recovery from diabetes in mice by beta cell regeneration. , 2007, The Journal of clinical investigation.
[34] D. Harlan,et al. T cell–directed therapies: lessons learned and future prospects , 2007, Nature Immunology.
[35] Yuichiro Yamada,et al. Follow-up Study of the First Successful Living Donor Islet Transplantation , 2006, Transplantation.
[36] D. Brennan,et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. , 2006, The New England journal of medicine.
[37] G. Camussi,et al. Antiangiogenic and Immunomodulatory Effects of Rapamycin on Islet Endothelium: Relevance for Islet Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] E. Kroon,et al. Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.
[39] P. van Endert,et al. HLA Class I Epitope Discovery in Type 1 Diabetes , 2006, Annals of the New York Academy of Sciences.
[40] Philippe Morel,et al. International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.
[41] J. Neilson,et al. Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function , 2006, Nature.
[42] N. Zhang,et al. Sirolimus Is Associated With Reduced Islet Engraftment and Impaired β-Cell Function , 2006, Diabetes.
[43] U. Christians,et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates , 2006, Nature Medicine.
[44] G. Korbutt,et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways , 2006, Nature Medicine.
[45] J. Neilson,et al. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. , 2006, Nature.
[46] J. Drijfhout,et al. Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes , 2005 .
[47] C. Paties,et al. Minimal Focal Steatosis of Liver after Islet Transplantation in Humans: A Long-Term Study , 2005, Cell transplantation.
[48] J. Drijfhout,et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Hunkeler,et al. Islet Auto‐Transplantation into an Omental or Splenic Site Results in a Normal Beta Cell but Abnormal Alpha Cell Response to Mild Non‐Insulin‐Induced Hypoglycemia , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[50] C. Ricordi,et al. Islet Transplantation in Type 1 Diabetes Mellitus Using Cultured Islets and Steroid‐Free Immunosuppression: Miami Experience , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[51] D. Roelen,et al. Alloreactivity Against Repeated HLA Mismatches of Sequential Islet Grafts Transplanted in Non-Uremic Type 1 Diabetes Patients , 2005, Transplantation.
[52] C. Ricordi,et al. Peripheral Blood Cytotoxic Lymphocyte Gene Transcript Levels Differ in Patients with Long-Term Type 1 Diabetes Compared to Normal Controls , 2005, Cell transplantation.
[53] A. Shapiro,et al. Five-year follow-up after clinical islet transplantation. , 2005, Diabetes.
[54] Michel Goldman,et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. , 2005, The New England journal of medicine.
[55] K. Ekdahl,et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. , 2005 .
[56] B. Hering,et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. , 2005, JAMA.
[57] N. Mueller,et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.
[58] R. Bottino,et al. Response of human islets to isolation stress and the effect of antioxidant treatment. , 2004, Diabetes.
[59] D. Harlan,et al. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. , 2004, The Journal of clinical investigation.
[60] C. Ricordi,et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. , 2004, Diabetes.
[61] C. Greenbaum,et al. Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. , 2004, The Journal of clinical endocrinology and metabolism.
[62] A. Shapiro,et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. , 2004, Diabetes.
[63] R. Robertson. Islet transplantation as a treatment for diabetes - a work in progress. , 2004, The New England journal of medicine.
[64] Mark Peakman,et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.
[65] J. Bluestone,et al. Beta-cell replacement for type I diabetes. , 2004, Annual review of medicine.
[66] C. Ricordi,et al. Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami. , 2004, Clinical transplants.
[67] D. Harlan,et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. , 2003, JAMA.
[68] U. Johansson,et al. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. , 2003, Biochemical and biophysical research communications.
[69] T. Starzl,et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.
[70] K. Ekdahl,et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation , 2002, The Lancet.
[71] S. H. A. Chen,et al. Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.
[72] J. Killestein. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. , 2002, The New England journal of medicine.
[73] J. Gaglia,et al. Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. , 2002, Diabetes.
[74] K. Ekdahl,et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. , 2002, Diabetes.
[75] E. Montanya,et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. , 2002, Diabetes.
[76] M. Peppelenbosch,et al. The Pleiotropic Effects of Tissue Factor: a Possible Role for Factor VIIa-induced Intracellular Signalling? , 2001, Thrombosis and Haemostasis.
[77] E. Bonifacio,et al. Autoantibody response to islet transplantation in type 1 diabetes. , 2001, Diabetes.
[78] E. Bonifacio,et al. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. , 2000, Diabetes.
[79] M. Brendel,et al. Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[80] Ames,et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .
[81] D. Becker,et al. Persistent T cell anergy in human type 1 diabetes. , 1999, Journal of immunology.
[82] Å. Lernmark,et al. Tolerance to kidney allograft transplanted into Type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches , 1999, Diabetologia.
[83] G. Elgue,et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? , 1999, Diabetes.
[84] Å. Lernmark,et al. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. , 1999, Diabetes.
[85] K. Salmela,et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft , 1998, Diabetologia.
[86] B. Hering,et al. Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts , 1997, Diabetes.
[87] P. Lacy,et al. Sensitization to HLA antigens in islet recipients with failing transplants. , 1997, Transplantation proceedings.
[88] C. Greenbaum,et al. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. , 1996, Journal of immunology.
[89] A. Weyrich,et al. Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.
[90] G. Abouna,et al. Site for unpurified islet transplantation is an important parameter for determination of the outcome of graft survival and function. , 1995, Cell transplantation.
[91] M. Field,et al. Effect of 15-Deoxyspergualin on Immediate Function and Long-Term Survival of Transplanted Islets in Murine Recipients of a Marginal Islet Mass , 1994, Diabetes.
[92] J. Lakey,et al. SURVIVAL AND FUNCTION OF PURIFIED ISLETS IN THE OMENTAL POUCH SITE OF OUTBRED DOGS , 1993, Transplantation.
[93] T. Edgington,et al. An Anti-Tissue Factor Monoclonal Antibody which Inhibits TF Vlla Complex Is a Potent Anticoagulant in Plasma , 1991, Thrombosis and Haemostasis.
[94] D. Dunn,et al. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts , 1990, The Journal of experimental medicine.
[95] Y. Mullen,et al. Destruction of islet isografts by severe nonspecific inflammation. , 1990, Transplantation proceedings.
[96] P. Lacy,et al. Insulin Independence After Islet Transplantation Into Type I Diabetic Patient , 1990, Diabetes.
[97] A. Gelet,et al. Islet Cell Autoimmunity in Type I Diabetic Patients After HLA-Mismatched Pancreas Transplantation , 1989, Diabetes.
[98] Cyclosporin-Induced Remission of IDDM After Early Intervention: Association of 1 yr of Cyclosporin Treatment With Enhanced Insulin Secretion , 1988, Diabetes.
[99] J. Nerup,et al. Cytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans , 1985, Allergy.
[100] J. Rosai,et al. The fate of intraportally transplanted islets in diabetic rats. A morphologic and immunohistochemical study. , 1978, The American journal of pathology.
[101] P. Lacy,et al. Transplantation of intact pancreatic islets in rats. , 1972, Surgery.
[102] A. Imbriano. [Blood coagulation]. , 1955, La Semana medica.